Cencora, Inc. COR

Latest FY: 2025 Healthcare Medical Distribution
Market Price $313.91
Market Cap $60.32B
P/E Ratio 39.44
Quick Peer Compare (Healthcare):
Revenue (FY 2025) ↑9.3% YoY
$321.33B
3-Yr CAGR: 10.4%
Net Income ↑3.0% YoY
$1.55B
Net Margin: 0.5%
Free Cash Flow ↑7.0% YoY
$3.21B
FCF Yield: 5.32%
EPS (Diluted) ↑5.7% YoY
$7.96
Basic: $8.02
Return on Equity Efficiency
103.1%
ROA: 2.0%
⚡ Elevated ROE due to low book equity from buybacks

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (COR)

All monetary values in millions ($M)
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Op. Cash Flow Free Cash Flow FCF YoY
FY 2016 $146,849.7M $4,272.6M $1,427.9M $6.32 $3,178.5M $2,713.9M
FY 2017 $153,143.8M +4.3% $4,546.0M $364.5M -74.5% $1.64 -74.1% $1,504.1M $1,037.7M -61.8%
FY 2018 $167,939.6M +9.7% $4,612.3M $1,658.4M +355.0% $7.53 +359.1% $1,411.4M $1,075.0M +3.6%
FY 2019 $179,589.1M +6.9% $5,138.3M $855.4M -48.4% $4.04 -46.3% $2,344.0M $2,033.8M +89.2%
FY 2020 $189,893.9M +5.7% $5,191.9M $-3,408.7M -498.5% $-16.65 -512.1% $2,207.0M $1,837.4M -9.7%
FY 2021 $213,988.8M +12.7% $6,943.2M $1,539.9M +145.2% $7.39 +144.4% $2,666.6M $2,228.4M +21.3%
FY 2022 $238,587.0M +11.5% $8,296.4M $1,698.8M +10.3% $8.04 +8.8% $2,703.1M $2,206.8M -1.0%
FY 2023 $262,173.4M +9.9% $8,959.5M $1,745.3M +2.7% $8.53 +6.1% $3,911.3M $3,453.0M +56.5%
FY 2024 $293,958.6M +12.1% $9,910.0M $1,509.1M -13.5% $7.53 -11.7% $3,484.7M $2,997.5M -13.2%
FY 2025 $321,332.8M +9.3% $11,478.5M $1,554.2M +3.0% $7.96 +5.7% $3,875.1M $3,207.1M +7.0%
$

Valuation

Market Price $313.91
Market Cap $60.32B
Enterprise Value $63.62B
P/E Ratio 39.44
P/B Ratio 40.50
FCF Yield 5.32%
Dividend Yield 0.70%
Shares Outstanding 194,561,100
%

Profitability & Margins

Gross Margin 3.57%
Operating Margin 0.82%
Net Margin 0.48%
Return on Equity (ROE) 103.06%
Return on Assets (ROA) 2.03%
Asset Turnover 4.20x
Revenue 3-Yr CAGR 10.43%
🛡️

Financial Health & Liquidity

Current Ratio 0.18
Cash Ratio 1.46
Debt / Equity 5.080
Debt / Assets 0.100
Cash & Equivalents $4.36B
Total Debt $7.66B
Book Value / Share $7.75
💧

Cash Flow Efficiency

Operating Cash Flow $3.88B
Capital Expenditures (CapEx) $667.98M
Free Cash Flow $3.21B
OCF / Revenue 1.21%
FCF / Revenue 1.00%
FCF 3-Yr CAGR 13.27%
🏷️

Per Share Metrics

EPS (Diluted) $7.96
EPS (Basic) $8.02
Dividends / Share $2.20
Book Value / Share $7.75
EPS YoY Growth 5.71%
🏛️

Balance Sheet (FY 2025)

Total Assets $76.59B
Total Liabilities $76.59B
Stockholders' Equity $1.51B
Current Assets $539.34M
Current Liabilities $2.98B